Published in Medical Letter on the CDC and FDA, August 20th, 2006
Used in more than 30 countries, the PRISM system was recently approved for use in the United States with its first hepatitis B test, PRISM HBcore, introduced in October. Additional hepatitis and retrovirus screening tests are currently under FDA review.
"We continue to focus on expanding our automated hepatitis testing menus across all of our diagnostic platforms," said Don Patton, vice...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.